Mr. Hanley is the former president of Covidien’s Imaging Solutions business unit with annual global revenue exceeding $1 billion. He led a multifunctional organization that included sales, marketing, logistics, manufacturing, as well as research and development. He has over 20 years experience selling and marketing medical device and pharmaceutical technologies globally.

Dr. Dorshow is a research physicist and manager with over 25 years in R&D focusing on business oriented research programs. He established and led the optical diagnostics and therapeutics program at Mallinckrodt. He constructed its IP position, and is co-inventor on over 60 US patents. He had the unique opportunity to launch MediBeacon under which he led acquisition of the technology, market research, IP and other related assets from Covidien.

Mr. Stern is a multi-lingual, global executive with a record of entrepreneurial achievement in the life sciences. As CEO and Founder of Vetbrands International he led the private equity backed management buyout of Ralston Purina’s pharmaceutical business in 2002 culminating in the sale of this Brazilian business to Ceva Santé Animale in 2007. Mr. Stern also held various general management and corporate development roles at Novus International.